Antimicrobial resistance determinants and future control

被引：192

作者：

Harbarth, S ^{[1
]}

Samore, MH

机构：

[1] Univ Hosp Geneva, Infect Control Program, CH-1211 Geneva, Switzerland

[2] VA Salt Lake City Hlth Care Syst, Salt Lake City, UT USA

来源：

EMERGING INFECTIOUS DISEASES | 2005年 / 11卷 / 06期

关键词：

D O I：

10.3201/eid1106.050167

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

At the beginning of the 21st century, antimicrobial resistance is common, has developed against every class of antimicrobial drug, and appears to be spreading into new clinical niches. We describe determinants likely to influence the future epidemiology and health impact of antimicrobial-resistant infections. Understanding these factors will ultimately optimize preventive strategies for an unpredictable future.

引用

页码：794 / 801

页数：8

共 41 条

[1] The biological cost of antibiotic resistance
Andersson, DI
Levin, BR
[J]. CURRENT OPINION IN MICROBIOLOGY, 1999, 2 (05) : 489 - 493
[2] Association between antibiotic sales and public campaigns for their appropriate use
Bauraind, I
Lopez-Lozano, JM
Beyaert, A
Marchal, JL
Seys, B
Yane, F
Hendrickx, E
Goossens, H
Tulkens, PM
Verbist, L
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (20): : 2468 - 2470
[3] Bavestrello L, 2002, REV MED CHILE, V130, P1265
[4] Public health interventions and SARS spread 2003
Bell, DM
[J]. EMERGING INFECTIOUS DISEASES, 2004, 10 (11) : 1900 - 1906
[5] Trends of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae in Europe
Bruinsma, N
Kristinsson, KG
Bronzwaer, S
Schrijnemakers, P
Degener, J
Tiemersma, E
Hryniewicz, W
Monen, J
Grundmann, H
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (06) : 1045 - 1050
[6] Regulating the use of antibiotics in the community
Carbon, C
Bax, RP
[J]. BRITISH MEDICAL JOURNAL, 1998, 317 (7159) : 663 - 665
[7] CHABBERT Y, 1952, PRESSE MED, V60, P1683
[8] The changing epidemiology of Staphylococcus aureus?
Chambers, HF
[J]. EMERGING INFECTIOUS DISEASES, 2001, 7 (02) : 178 - 182
[9] Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults - A randomized trial
Chastre, J
Wolff, M
Fagon, JY
Chevret, S
Thomas, F
Wermert, D
Clementi, E
Gonzalez, J
Jusserand, D
Asfar, P
Perrin, D
Fieux, F
Aubas, S
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (19): : 2588 - 2598
[10] Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections:: cluster-randomised, single-blinded intervention trial
Christ-Crain, M
Jaccard-Stolz, D
Bingisser, R
Gencay, MM
Huber, PR
Tamm, M
Müller, B
[J]. LANCET, 2004, 363 (9409) : 600 - 607

← 1 2 3 4 5 →